Brooks Automation

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Azenta

CHELMSFORD, Mass. , Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes.

Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast

CHELMSFORD, Mass. , Oct. 3, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has closed its previously announced acquisition of B Medical Systems S.

Azenta Announces Completion of B Medical Systems Acquisition

CHELMSFORD, Mass. , Sept. 6, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2022 Global Healthcare Conference in New York City, on Wednesday, September 14, 2022, which includes a presentation beginning at 9:40 am ET.

Azenta to Participate in the Baird 2022 Global Healthcare Conference

CHELMSFORD, Mass. , Aug. 30, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 20th Annual Global Healthcare Conference in New York City, on Tuesday, September 13, 2022, which includes a presentation beginning at 4:40 pm ET.

Azenta to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

CHELMSFORD, Mass. , Aug. 11, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022.

Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

CHELMSFORD, Mass. , Aug. 9, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2022.

Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022

Enhances Azenta's Leadership Position in Cold Chain Solutions and End-to-End Sample Management CHELMSFORD, Mass. , Aug. 8, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into a definitive agreement to acquire B Medical Systems S.

Azenta Announces Agreement to Acquire B Medical Systems

CHELMSFORD, Mass. , Aug. 5, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, CA, on Thursday, August 11, 2022, which includes a presentation beginning at 4:00 pm PT.

Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

CHELMSFORD, Mass. , July 27, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the opening of its new China headquarters in Suzhou, which serves as the hub for Azenta operations in the Asia Pacific region.

Azenta Celebrates Opening of New China Headquarters

CHELMSFORD, Mass. , July 13, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported preliminary results for its third fiscal quarter ended June 30, 2022.

Azenta Reports Preliminary Results for Third Quarter of Fiscal 2022, Ended June 30, 2022 and Announces Earnings Conference Call and Webcast

CHELMSFORD, Mass. , July 1, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has closed its previously announced acquisition of Barkey Holding GmbH and its subsidiaries ("Barkey"), a leading provider of controlled rate thawing devices for customers in the medical, biotech and pharmaceutical industries.

Azenta Announces Completion of Barkey Holding GmbH Acquisition

CHELMSFORD, Mass. , June 8, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into a definitive agreement to acquire Barkey Holding GmbH and its subsidiaries ("Barkey"), a leading provider of controlled rate thawing devices to medical, biotech and pharma industries.

Azenta Announces Agreement to Acquire Barkey Holding GmbH

CHELMSFORD, Mass. , May 19, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Global Healthcare Conference in New York, on Tuesday, May 24, 2022, which includes a presentation beginning at 2:45 pm ET.

Azenta to Participate in the UBS Global Healthcare Conference

Robust customer demand bolstered by operational execution drives strong second quarter results CHELMSFORD, Mass., May 9, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported preliminary financial results for the second quarter ended March 31, 2022.

Azenta Life Sciences Reports Preliminary Results of Second Quarter of Fiscal 2022, Ended March 31, 2022

CHELMSFORD, Mass., April 28, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has rescheduled the release of its earnings for the second fiscal quarter of 2022 which ended on March 31, 2022 from Tuesday, May 3, 2022 to Monday, May 9, 2022 after the market closes.

Azenta Reschedules Fiscal 2022 Second Quarter Earnings Conference Call and Webcast

CHELMSFORD, Mass. , April 14, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal 2022 second quarter earnings which ended on March 31, 2022 on Tuesday, May 3, 2022 after the market closes.

Azenta Life Sciences Announces Fiscal 2022 Second Quarter Earnings Conference Call and Webcast

CHELMSFORD, Mass. , March 30, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022, which includes a presentation beginning at 9:30am ET.

Azenta to Participate in the 21st Annual Needham Virtual Healthcare Conference

CHELMSFORD, Mass., March 11, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 22, 2022, which includes a presentation beginning at 3:00pm ET.

Azenta to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

CHELMSFORD, Mass., March 1, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Barclays Global Healthcare Conference on Tuesday, March 15, 2022, which includes a presentation beginning at 10:15am ET.

Azenta to Participate in the Barclays Global Healthcare Conference

CHELMSFORD, Mass., Feb. 4, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 15, 2022, which includes a presentation beginning at 10:30 a.m.

Azenta Life Sciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

CHELMSFORD, Mass., Jan. 6, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th.

Azenta Life Sciences Names Matthew McManus Chief Operating Officer

CHELMSFORD, Mass., Dec. 21, 2021 /PRNewswire/ -- Azenta, Inc. (Nasdaq:AZTA) announced today that company management will participate in the 40th Annual J.P.

Azenta Life Sciences to Participate in the 40th Annual J.P. Morgan Conference

CHELMSFORD, Mass., Dec. 20, 2021 /PRNewswire/ -- Azenta, Inc. (Nasdaq:AZTA) announced today that company management will participate in the 24th Annual Needham Virtual Growth Conference on Monday, January 10, 2022 which includes a webcast beginning at 1:15 p.m.

Azenta Life Sciences to Participate in the 24th Annual Needham Virtual Growth Conference

Azenta Inc. AZTA, -2.73% , formerly known as life sciences solutions company Brooks Automation Inc., said Wednesday that its stock will begin trading under a new ticker -- "AZTA" -- after the opening bell. The previous ticker was "BRKS.

Azenta, the former Brooks Automation to begin trading under new ticker

CHELMSFORD, Mass., Nov. 18, 2021 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Stephens Annual Investment Conference on Friday, December 3, 2021 which includes a webcast beginning at 1:00 p.m.

News for Brooks Automation Stock (BRKS)